Small Cell Lung Cancer (SCLC) Clinical Trials

Find Small Cell Lung Cancer (SCLC) Clinical Trials Near You

Engagement of Veterans With Lung Cancer (EVLC)

Status: Recruiting
Location: See location...
Intervention Type: Other, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Veteran patients with diagnosis of any stage of lung cancer;

• 18 years of age or older;

• English- or Spanish-speaking;

• can self-administer questionnaires in English or Spanish;

• valid telephone number;

• receiving oncology care at participating sites;

• currently newly diagnosed or receiving or having completed systemic anti-cancer therapy and/or radiation therapy within 12 months, defined as oral, injection, or intravenous therapy (chemotherapy, targeted therapy, or immunotherapy)

Locations
United States
California
Veterans Affairs Palo Alto Health Care System (VAPAHCS)
RECRUITING
Palo Alto
Contact Information
Primary
Manali I Patel, MD MPH MS
manalip@stanford.edu
6504935000
Backup
Madhuri Agrawal, MS
madhuri.agrawal@va.gov
650-304-7744
Time Frame
Start Date: 2026-02-27
Estimated Completion Date: 2032-12-31
Participants
Target number of participants: 194
Treatments
Active_comparator: Usual Care - Arm A
Patients randomized to this group will receive usual care provided by their oncology(or primary) clinical team.
Experimental: Intervention Lay Health Worker (LHW) - Arm B
Participants randomized to this arm of the study will receive usual care with supplemental education and support provided by a lay health worker (LHW) to assist with healthcare planning, symptom management, and discussions about care preferences and goals.
Sponsors
Collaborators: United States Department of Defense, US Department of Veterans Affairs
Leads: Palo Alto Veterans Institute for Research

This content was sourced from clinicaltrials.gov